Home › Funds › PEREGRINE INVESTMENT MANAGEMENT INC › BEAM

PEREGRINE INVESTMENT MANAGEMENT INC position in BEAM

BEAM THERAPEUTICS INC · Health Care

PEREGRINE INVESTMENT MANAGEMENT INC reported holding 309,030 shares of BEAM (BEAM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.6M, representing 4.30% of its reported portfolio and ranking #13 among its reported holdings. PEREGRINE INVESTMENT MANAGEMENT INC has disclosed BEAM holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)309.03K sh
Reported value held$7.56M
Portfolio Weight4.30%
First reportedQ4 2024
Last changeAdd
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How PEREGRINE INVESTMENT MANAGEMENT INC's BEAM position evolved

PEREGRINE INVESTMENT MANAGEMENT INC first disclosed a stake in BEAM in Q4 2024 at 158,550 shares (US$3.9M). The position peaked in Q3 2026 at 309,030 shares, worth US$7.6M. Across 8 filings, PEREGRINE INVESTMENT MANAGEMENT INC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 309,030 shares valued at US$7.6M — an increase of 239,030 shares quarter over quarter.. Notable position changes include a 41% increase in Q1 2025 (shares fell 12% over the following quarter), a 73% trim in Q2 2026 (shares fell 32% over the following quarter), a 341% increase in Q3 2026 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 158.55K $3.93M New
Q1 2025 224.26K $4.38M Add
Q2 2025 264.26K $4.50M Add
Q3 2025 267.93K $6.50M Add
Q4 2025 257.28K $7.13M Reduce
Q1 2026 260.05K $6.20M Add
Q2 2026 70.00K $2.40M Reduce
Q3 2026 309.03K $7.56M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BEAM and 13F data

BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), ARK Invest (US$351.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BEAM

All BEAM fund holders →

FAQ

How long has PEREGRINE INVESTMENT MANAGEMENT INC held BEAM?

PEREGRINE INVESTMENT MANAGEMENT INC has disclosed BEAM holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is PEREGRINE INVESTMENT MANAGEMENT INC's current position in BEAM?

As of Q3 2026, PEREGRINE INVESTMENT MANAGEMENT INC holds 309.03K shares of BEAM (BEAM THERAPEUTICS INC), valued at $7.56M, representing 4.30% of its reported portfolio and ranking #13.

Has PEREGRINE INVESTMENT MANAGEMENT INC been buying or selling BEAM?

In the latest 13F filing (Q3 2026), PEREGRINE INVESTMENT MANAGEMENT INC increased its position in BEAM. The position peaked in Q3 2026 at 309.03K shares.

Which other funds hold BEAM?

Other major institutional holders of BEAM include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARK Invest, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.